tetramethylpyrazine has been researched along with Parkinson Disease in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guo, B; Lee, SM; Li, C; Li, H; Lu, J; Lu, Y; Shao, M; Wang, Y; Yang, X; Zhang, Z; Zhong, H; Zhou, H; Zhu, Q | 1 |
| Du, J; Duan, H; Guo, B; Lee, SM; Wang, Y; Xu, D; Zhang, Z | 1 |
| Han, Y; Hu, S; Hu, Y; Lee, SM; Li, H; Li, Y; Mak, S; Wang, L; Wang, Y; Xu, D; Zhang, Z | 1 |
| Abdel-Tawab, AM; Esmat, A; Khalifa, AE; Michel, HE; Tadros, MG | 1 |
4 other study(ies) available for tetramethylpyrazine and Parkinson Disease
| Article | Year |
|---|---|
Tetramethylpyrazine Analogue T-006 Promotes the Clearance of Alpha-synuclein by Enhancing Proteasome Activity in Parkinson's Disease Models.
Topics: alpha-Synuclein; Animals; Dose-Response Relationship, Drug; Humans; Hydrazones; Mice; Mice, Transgenic; Parkinson Disease; PC12 Cells; Proteasome Endopeptidase Complex; Pyrazines; Rats; Vasodilator Agents | 2019 |
Therapeutic effects of multifunctional tetramethylpyrazine nitrone on models of Parkinson's disease in vitro and in vivo.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; Animals; Antioxidants; Behavior, Animal; Disease Models, Animal; Dopamine; Dopaminergic Neurons; Humans; Ligusticum; Male; Neuroprotective Agents; Nitrogen Oxides; Oxidative Stress; Oxidopamine; Parkinson Disease; Phytotherapy; Plant Extracts; Pyrazines; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Substantia Nigra; Zebrafish | 2014 |
Potent Protection Against MPP
Topics: Animals; Cell Line; Cells, Cultured; Drugs, Chinese Herbal; Enzyme Activation; MEF2 Transcription Factors; Neurons; Neuroprotective Agents; Parkinson Disease; Phosphatidylinositol 3-Kinases; Pyrazines; Rats; Transcriptional Activation | 2016 |
Tetramethylpyrazine Ameliorates Rotenone-Induced Parkinson's Disease in Rats: Involvement of Its Anti-Inflammatory and Anti-Apoptotic Actions.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Apoptosis; Brain; Cyclooxygenase 2; Disease Models, Animal; Male; Neuroprotective Agents; Oxidative Stress; Parkinson Disease; Pyrazines; Rats, Sprague-Dawley; Rotenone; Vasodilator Agents | 2017 |